Cancer patient’s claim denied despite medical support: RC

13 September 2018
| By Hannah |
image
image
expand image

The Royal Commission has today heard that a CommInsure customer was denied a claim following breast cancer surgery as she did not have to undergo a full mastectomy, despite two doctors confirming to the insurer that her procedure was “radical breast cancer surgery”.

CommInsure’s definition of what “radical” surgery was that was needed to make a successful claim was not specified, but its managing director, Helen Troup, acknowledged it relied on a definition of cancer that was 18 years old and had limitations imposed on it which were not referred to in any of its policy documents.

These limitations were also imposed in a way which didn’t account for the way the customer had been treated by her doctors or the medical opinions expressed by those doctors. This revelation came just hours after the Commission heard evidence that CommInsure’s definition of a heart attack was outdated.

After the customer’s original claim was denied for not being “radical”, she got evidence from both the surgeon who operated on her and her GP that, in their medical opinion, the procedure she underwent was “radical”.

CommInsure’s medical consultant again denied the claim in light of the new supporting documentation and, when it was escalated to the firm’s operational claims committee, where claims could be discussed amongst various members of the complaints team, the denial was upheld.

The letter confirming the denial received by the customer on 15 March 2017 said: “We appreciate that radical surgery is not defined in the relevant product disclosure, however radical surgery pertaining to the breast means radical mastectomy, which refers to the removal of the entire affected breast.”

When asked whether the reliance on an older definition or the above limitations was acceptable by Senior Counsel assisting the Commission, Rowena Orr QC, Troup admitted that this was not.

“I think that there were two errors that CommInsure’s processes and procedures should have addressed and they didn’t,” Troup said.

She said that firstly, the difference in medical opinion between the claimant’s doctors and CommInsure’s medical team should have been reviewed and resolved, and the review should have then been escalated to a higher level.

“I think if those two things had happened [the claim] would have resulted in a different outcome,” Troup said.

CommInsure did not update its definition around breast cancer until May, last year.

Read more about:

AUTHOR

Add new comment

The content of this field is kept private and will not be shown publicly.

Recommended for you

sidebar subscription

Never miss the latest developments in Super Review! Anytime, Anywhere!

Grant Banner

From my perspective, 40- 50% of people are likely going to be deeply unhappy about how long they actually live. ...

4 months ago
Kevin Gorman

Super director remuneration ...

4 months 1 week ago
Anthony Asher

No doubt true, but most of it is still because over 45’s have been upgrading their houses with 30 year mortgages. Money ...

4 months 1 week ago

Blue Owl Capital, a US asset manager with its eye on ‘marquee investors’ like super funds, has announced the appointment of a senior Future Fund executive as its newest m...

2 days ago

Australia’s second-largest super fund has confirmed it is expanding its presence in the UK following significant investment in the region....

2 days 16 hours ago

While the Financial Advice Association Australia said it supports a performance testing regime “in principle”, it holds reservations about expanding this scope to retirem...

2 days 6 hours ago

TOP PERFORMING FUNDS

ACS FIXED INT - AUSTRALIA/GLOBAL BOND